← Evidence map

ArticleAmerican journal of preventive cardiology2026

Quantifying population-level antihypertensive treatment eligibility under the 2025 AHA/ACC hypertension guideline: What has changed - And where the greatest opportunity remains.

Huanhuan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41767441